SFN 2014

Recent articles

Autism gene needed for growth of neurons during gestation

Mutations in one of the strongest autism candidate genes may block the proliferation of neurons during development.

By Jessica Wright
7 October 2016 | 5 min read

Enriched environment staves off autism-like behavior in rats

Rats exposed in utero to the epilepsy drug valproic acid, a risk factor for autism, do not develop autism-like behaviors if they are reared in a stimulating environment. Researchers presented the unpublished findings yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Nicholette Zeliadt
20 November 2014 | 3 min read

Who are you going to believe, your body or your lying eyes?

Children with autism tend to rely more on their bodies when learning new motor skills, while controls rely more on their eyes, suggests unpublished research presented Wednesday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Sarah DeWeerdt
20 November 2014 | 3 min read

Feisty mice may reveal autism gene’s link to aggression

Varying the number of copies of a single autism-linked gene modulates social behavior and aggression in mice, according to unpublished results presented yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Jessica Wright
20 November 2014 | 3 min read

Takeaways from SfN 2014

Scientists reflect on the current state of autism research as the 2014 Society for Neuroscience annual meeting in Washington, D.C. comes to a close.

By Greg Boustead
20 November 2014 | 4 min read

Different autism subtypes share same genetic signature

A rare form of autism linked to a duplication of the 15q11-13 chromosomal region shares a molecular signature with more common forms of the disorder, suggests unpublished research presented yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Katie Moisse
20 November 2014 | 3 min read

Monkey missing Rett gene prompts primate research debate

Scientists have created a transgenic monkey modeling Rett syndrome, they announced yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C. This model and others sparked a lively discussion about the relative value of animal models in research.

By Virginia Hughes
20 November 2014 | 4 min read

In autism, RNA snippets vary little by brain region, age

The expression patterns of microRNAs vary less by brain region and age in people with autism than in controls. Researchers presented the unpublished findings Tuesday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Nicholette Zeliadt
20 November 2014 | 3 min read

Robots come to the rescue in sensory processing studies

Robots that help children with autism become more socially engaged may also increase understanding of sensory processing in the disorder, suggests unpublished research presented today at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Sarah DeWeerdt
20 November 2014 | 3 min read

In mouse model of Rett, immune cells overly sensitive

Loss of MeCP2, the Rett syndrome gene, depletes immune cells throughout the bodies of mice, researchers reported yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Jessica Wright
20 November 2014 | 3 min read

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read